Advanced Enzyme Technologies surges on getting nod to acquire additional stake of 5.89% in JC Biotech
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Advanced Enzyme Technologies is currently trading at Rs. 388.85, up by 7.75 points or 2.03% from its previous closing of Rs. 381.10 on the BSE.
The scrip opened at Rs. 404.50 and has touched a high and low of Rs. 406.15 and Rs. 388.00 respectively. So far 22265 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 406.15 on 12-Feb-2024 and a 52 week low of Rs. 225.00 on 28-Mar-2023.
Last one week high and low of the scrip stood at Rs. 406.15 and Rs. 366.60 respectively. The current market cap of the company is Rs. 4357.78 crore.
The promoters holding in the company stood at 43.62%, while Institutions and Non-Institutions held 29.52% and 26.87% respectively.
Advanced Enzyme Technologies has received approval for the acquisition of an additional stake of upto 5.89% of JC Biotech (existing 89.83% subsidiary) by way of purchase of upto 12,18,976 Equity Shares from few existing shareholders of JC Biotech (Transferors) for the total consideration not exceeding Rs 5.60 crore (i.e. upto Rs 46 per share). The Board of Directors of the Company at its Meeting held on February 10, 2024 has approved the same.
The company is a fully integrated enzyme manufacturing company driven by extensive focus on research and development (R&D) of various enzymes, enzyme blends, enzyme products and customized enzyme solutions.
